Title : Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy.

Pub. Date : 2020 Sep

PMID : 32472692






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy. Metformin Wistar clone pR53P1 p53 pseudogene Rattus norvegicus
2 In addition, our data indicated that metformin increased the radiosensitivity of colorectal tumours with P53 mutation both in vitro and in vivo. Metformin Wistar clone pR53P1 p53 pseudogene Rattus norvegicus
3 CONCLUSION AND IMPLICATIONS: Metformin may be a radiotherapy adjuvant agent for colorectal cancers especially those carrying P53 mutation. Metformin Wistar clone pR53P1 p53 pseudogene Rattus norvegicus